Silencing SATB1 with siRNA inhibits the proliferation and invasion of small cell lung cancer cells

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Huang, Bo ^a   Zhou, Hongli ^a   Wang, Xiaodong ^a   Liu, Zhiliang ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; SATB1; siRNA interfering; Small cell lung cancer

Indexed keywords

NUCLEAR MATRIX PROTEIN; RNA; SMALL INTERFERING RNA; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; PROTEIN EXPRESSION;

EID: 84873264989     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-8     Document Type: Article

References (23)

1. Lally BE, Urbanic JJ, Blackstock AW, Miller AA, Perry MC. Small cell lung cancer: have we made any progress over the last 25 years?. Oncologist 2007, 12(9):1096-1104. 10.1634/theoncologist.12-9-1096, 17914079.
2. Nakayama Y, Mian IS, Kohwi-Shigematsu T, Ogawa T. A nuclear targeting determinant for SATB1, a genome organizer in the T cell lineage. Cell Cycle 2005, 4(8):1099-1106.
3. Cai S, Han HJ, Kohwi-Shigematsu T. Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet 2003, 34(1):42-51. 10.1038/ng1146, 12692553.
4. Wen J, Huang S, Rogers H, Dickinson LA, Kohwi-Shigematsu T, Noguchi CT. SATB1 family protein expressed during early erythroid differentiation modifies globin gene expression. Blood 2005, 105(8):3330-3339. 10.1182/blood-2004-08-2988, 15618465.
5. Nie H, Yao X, Maika SD, Tucker PW. SATB1 is required for CD8 coreceptor reversal. Mol Immunol 2008, 46(1):207-211. 10.1016/j.molimm.2008.07.007, 18722016.
6. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008, 452(7184):187-193. 10.1038/nature06781, 18337816.
7. Cheng C, Lu X, Wang G, Zheng L, Shu X, Zhu S, Liu K, Wu K, Tong Q. Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica 2010, 118(11):855-863. 10.1111/j.1600-0463.2010.02673.x, 20955458.
8. Lu X, Cheng C, Zhu S, Yang Y, Zheng L, Wang G, Shu X, Wu K, Liu K, Tong Q. SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol Rep 2010, 24(4):981-987.
9. Tu W, Luo M, Wang Z, Yan W, Xia Y, Deng H, He J, Han P, Tian D. Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer. Liver Int 2012, 32(7):1064-1078. 10.1111/j.1478-3231.2012.02815.x, 22583549.
10. Chu SH, Ma YB, Feng DF, Zhang H, Zhu ZA, Li ZQ, Jiang PC. Upregulation of SATB1 is associated with the development and progression of glioma. J Transl Med 2012, 10:149. 10.1186/1479-5876-10-149, 3492129, 22839214.
11. Nodin B, Johannesson H, Wangefjord S, DP OC, Ericson-Lindquist K, Uhlen M, Jirstrom K, Eberhard J. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer. Diagn Pathol 2012, 7(1):115. 10.1186/1746-1596-7-115, 3523011, 22935204.
12. Meng WJ, Yan H, Zhou B, Zhang W, Kong XH, Wang R, Zhan L, Li Y, Zhou ZG, Sun XF. Correlation of SATB1 overexpression with the progression of human rectal cancer. Int J Colorectal Dis 2012, 27(2):143-150. 10.1007/s00384-011-1302-9, 21870058.
13. Zheng J. Is SATB1 a master regulator in breast cancer growth and metastasis?. Womens Health (Lond Engl) 2008, 4(4):329-332.
14. Neznanov N, Kohwi-Shigematsu T, Oshima RG. Contrasting effects of the SATB1 core nuclear matrix attachment region and flanking sequences of the keratin 18 gene in transgenic mice. Mol Biol Cell 1996, 7(4):541-552. 275908, 8730098.
15. Zimmerman MA, Rahman NT, Yang D, Lahat G, Lazar AJ, Pollock RE, Lev D, Liu K. Unphosphorylated SATB1 promotes sarcoma development through repressing expression of Fas and bad and conferring apoptotic resistance. Cancer Res 2012, 72(18):4724-4732. 10.1158/0008-5472.CAN-12-1347, 22805310.
16. Hubackova S, Krejcikova K, Bartek J, Hodny Z. Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells. J Biol Chem 2012, 287(32):26702-26714. 10.1074/jbc.M111.316869, 22711534.
17. Moore F, Cunha DA, Mulder H, Eizirik DL. Use of RNA interference to investigate cytokine signal transduction in pancreatic beta cells. Methods Mol Biol 2012, 820:179-194. 10.1007/978-1-61779-439-1_11, 22131032.
18. Su F, Li H, Yan C, Jia B, Zhang Y, Chen X. Depleting MEKK1 expression inhibits the ability of invasion and migration of human pancreatic cancer cells. J Cancer Res Clin Oncol 2009, 135(12):1655-1663. 10.1007/s00432-009-0612-6, 19513748.
19. Hanker LC, Karn T, Mavrova-Risteska L, Ruckhaberle E, Gaetje R, Holtrich U, Kaufmann M, Rody A, Wiegratz I. SATB1 gene expression and breast cancer prognosis. Breast 2011, 20(4):309-313. 10.1016/j.breast.2010.10.002, 20980149.
20. Li QQ, Chen ZQ, Xu JD, Cao XX, Chen Q, Liu XP, Xu ZD. Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells. Cancer Sci 2010, 101(1):80-86. 10.1111/j.1349-7006.2009.01372.x, 19860849.
21. Patani N, Jiang W, Mansel R, Newbold R, Mokbel K. The mRNA expression of SATB1 and SATB2 in human breast cancer. Cancer Cell Int 2009, 9:18. 10.1186/1475-2867-9-18, 2731048, 19642980.
22. Selinger CI, Cooper WA, Al-Sohaily S, Mladenova DN, Pangon L, Kennedy CW, McCaughan BC, Stirzaker C, Kohonen-Corish MR. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. J Thorac Oncol 2011, 6(7):1179-1189. 10.1097/JTO.0b013e31821b4ce0, 21597389.
23. Zhou LY LF, Tong J, Chen QQ, Zhang FW. Expression of special AT-rich sequence-binding protein mRNA and its clinicopathological significance in non-small cell lung cancer. Nan fang yi ke da xue xue bao = J South Med Univ 2009, 29:534-537.